Literature DB >> 31512934

A review of methods for solubility determination in biopharmaceutical drug characterization.

Ardita Veseli1, Simon Žakelj1, Albin Kristl1.   

Abstract

The significance of thermodynamic solubility in biopharmaceutical compound or drug characterization as well as the importance of having methods that accurately establish it have been extensively addressed. Nonetheless, its precise determination continues to remain a challenging task to accomplish. Even more so when the number of compounds to evaluate is high and the available amount of each compound is low, both of which are inevitable for the compound characterization during the drug development process. Except for the shake-flask method which is still considered as the 'gold standard' in obtaining thermodynamic data, it is currently difficult to say that another satisfactory model which is routinely used to determine thermodynamic solubility is being applied. Therefore, this review summarizes the various experimental approaches which are based on the classical shake flask method but have yet attempted to speed up the experimental process of obtaining such data more conveniently. The most important experimental features of these approaches are provided to the reader. Some advantages and disadvantages associated with each approach are also highlighted, consequently offering a resource to those looking for the most appropriate of the approaches that have already fared well at determining the biopharmaceutically relevant drug solubility.

Keywords:  Biopharmaceutical drug solubility; high throughput; miniaturized assays; shake flask method; thermodynamic (equilibrium) solubility

Mesh:

Substances:

Year:  2019        PMID: 31512934     DOI: 10.1080/03639045.2019.1665062

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  6 in total

1.  Development and Characterization of Eudragit® EPO-Based Solid Dispersion of Rosuvastatin Calcium to Foresee the Impact on Solubility, Dissolution and Antihyperlipidemic Activity.

Authors:  Sana Inam; Muhammad Irfan; Noor Ul Ain Lali; Haroon Khalid Syed; Sajid Asghar; Ikram Ullah Khan; Salah-Ud-Din Khan; Muhammad Shahid Iqbal; Imran Zaheer; Ahmed Khames; Heba A Abou-Taleb; Mohammad A S Abourehab
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-18

2.  Acute toxicity analysis of an inhibitor of BCL2, Disarib, in rats.

Authors:  Shivangi Sharma; Kontham Kulangara Varsha; Ujjayinee Ray; Humaira Siddiqua; Anjana Elizabeth Jose; Sridhar Muninarasimaiah; Sathees C Raghavan; Bibha Choudhary
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

Review 3.  Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data.

Authors:  Andreas Bender; Isidro Cortes-Ciriano
Journal:  Drug Discov Today       Date:  2021-01-27       Impact factor: 7.851

4.  Docking-guided rational engineering of a macrolide glycosyltransferase glycodiversifies epothilone B.

Authors:  Peng Zhang; Lijuan Zhang; Xukai Jiang; Xiao-Tong Diao; Shuang Li; Dan-Dan Li; Zheng Zhang; Junqiang Fang; Ya-Jie Tang; Da-Lei Wu; Changsheng Wu; Yue-Zhong Li
Journal:  Commun Biol       Date:  2022-01-27

5.  Midecamycin Is Inactivated by Several Different Sugar Moieties at Its Inactivation Site.

Authors:  Ru Lin; Li-Li Hong; Zhong-Ke Jiang; Ke-Meng Li; Wei-Qing He; Jian-Qiang Kong
Journal:  Int J Mol Sci       Date:  2021-11-23       Impact factor: 5.923

6.  Thymoquinone Loaded Topical Nanoemulgel for Wound Healing: Formulation Design and In-Vivo Evaluation.

Authors:  Mohammed S Algahtani; Mohammad Zaki Ahmad; Ibrahim Ahmed Shaikh; Basel A Abdel-Wahab; Ihab Hamed Nourein; Javed Ahmad
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.